Oxford Pharm Gp Share Discussion Threads

[greedfear] 23/2/2017 09:03

I'm not sure they've given up on the GI part.

"This study is to help development of a new version of Ibuprofen, called Ibuprofen-LDH. Ibuprofen-LDH will be used as a treatment for muscular pains, headache, fever etc. This new version of ibuprofen is expected to produce fewer stomach/intestine related side effects when compared to many existing marketed formulations of Ibuprofen."



I sure hope they haven't as I see the GI part as the most interesting.

[pugugly] 23/2/2017 08:53

timbo003.
Can you translate please into consumer speak and also have you changed your mind about the technology (your post 730 above) so as to make this worth looking at again.

[timbo003] 23/2/2017 08:45

Good to see that they have given up trying to obtain GI safe claims for an OTC formula, as this was always a non-starter as far as I was concerned. I doubt if they will get improved taste masking with faster acting, but they should be able to achieve taste masking without the speed claims.

[greedfear] 23/2/2017 08:28

Very good news. Having trust in an increasing share price

[barnetpeter] 23/2/2017 07:57

Update...we need advice from the experts on this.

[113mike] 21/2/2017 14:02

hmmm..has been a bit quiet lately

[barnetpeter] 21/2/2017 13:54

another million buy gone through. Serious cash

[meanwhile back at the ranch] 15/2/2017 00:33

Quite happy with that.

[risk1] 10/2/2017 13:58

They are at it

Dropped the share price over lunch to gather shares for the one million buyer

[risk1] 09/2/2017 10:21

Quite some drop as well

Was the drop justified?

[barnetpeter] 09/2/2017 10:14

It's been some rally! The news needs to be very good I guess to justify this re rating but the 22 million in cash 💰 always puts a limit on the downside. I wonder if some company is sniffing around?

[nick rubens] 09/2/2017 09:57

News can land anytime and if it's good then a rerate will ensue.

"Dosing for all three study parts is due to complete by the end of the second quarter of 2017, with first readouts are also expected in the second quarter.

Oxford Pharmascience also said it expects responses from the US Food and Drug Administration over the regulatory pathway for OXPzero ibuprofen in the first quarter of 2017."

[donald trumpton] 08/2/2017 16:02

..and so it came to pass..

[donald trumpton] 08/2/2017 09:38

This is just how OXP moves don't you know.

[trickster1] 08/2/2017 09:27

very nice. Vertical take off.

FOLLOW HASHTAG TRICKSTER

1.8M FOLLOWERS

[burbelly] 08/2/2017 09:25

Like yesterday any sells get soaked up and forward it goes again

[nick rubens] 08/2/2017 09:24

Feels like a reasonable 6p on it's way and especially if an update includes a customer win. Seeing Woodford funding itat 10p gives me confidence not to risk trading out of it. Could be one of those where buying on the way up on any dips makes sense this time. I may have to pluck up the courage to do that myself.

[barnetpeter] 08/2/2017 09:13

Flying again. Doubled for me. Taken my stake out now in full and will wait for news. Those who were selling at 1.6 and below cash a short while ago must be fed up

[risk1] 07/2/2017 14:33

Not sure other than news flow due this quarter

And 20 million in the bank plus woodford on the share register

[bullet ant] 07/2/2017 14:25

why is going up today?

[bullet ant] 07/2/2017 14:20

No mate.

Traded DX.

This was previously on my watchlist. I saw you talking about it yesterday :)


BOWL formation here

[risk1] 07/2/2017 13:43

Bought a few below 2p when the muppets were buying old oil n gas

[risk1] 07/2/2017 13:36

Yes mate did you get in?

[bullet ant] 07/2/2017 13:35

Risk1

Nice1